0001144204-18-028462.txt : 20180515 0001144204-18-028462.hdr.sgml : 20180515 20180515094155 ACCESSION NUMBER: 0001144204-18-028462 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 EFFECTIVENESS DATE: 20180515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management II, LLC CENTRAL INDEX KEY: 0001594912 IRS NUMBER: 464028844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16497 FILM NUMBER: 18833639 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001594912 XXXXXXXX 03-31-2018 03-31-2018 false Foresite Capital Management II, LLC

600 Montgomery Street Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-16497 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 05-15-2018 0 11 300625 INFORMATION TABLE 2 infotable.xml Acceleron Pharma Inc. COM 00434H108 9570 244756 SH SOLE 244756 0 0 Adaptimmune Therapeutics PLC SPONDS ADR 00653A107 4492 400000 SH SOLE 400000 0 0 Aerie Pharmaceuticals, Inc. COM 00771V108 90745 1672714 SH SOLE 1672714 0 0 Aimmune Therapeutics, Inc. COM 00900T107 105674 3319945 SH SOLE 3319945 0 0 Aimmune Therapeutics, Inc. COM 00900T957 13900 437900 SH Put SOLE 437900 0 0 Alder BioPharmaceuticals, Inc. COM 014339105 21415 1686220 SH SOLE 1686220 0 0 Ardelyx Inc. COM 039697107 808 159967 SH SOLE 159967 0 0 Denali Therapeutics Inc. COM 24823R105 3697 250000 SH SOLE 250000 0 0 Epizyme, Inc. COM 29428V104 27656 1558108 SH SOLE 1558108 0 0 Insmed Incorporated COM 457669307 21791 967636 SH SOLE 967636 0 0 Sangamo Therapeutics, Inc. COM 800677106 877 46138 SH SOLE 46138 0 0